Detalles de la búsqueda
1.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Lancet
; 403(10441): 2293-2306, 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38705160
2.
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.
Blood
; 140(4): 349-358, 2022 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316325
3.
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
Eur J Nucl Med Mol Imaging
; 51(5): 1361-1370, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114616
4.
Single-center experience of patients with plasma cell leukemia in the era of new therapeutics.
Acta Haematol
; 2024 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38763126
5.
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma.
Ann Hematol
; 102(12): 3445-3455, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37566280
6.
Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variant.
Eur J Haematol
; 109(4): 364-372, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35751531
7.
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial.
Hematology
; 29(1): 2320006, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38407192
8.
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.
Sci Rep
; 13(1): 13111, 2023 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37573446
9.
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy.
Hemasphere
; 7(1): e817, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36698613
10.
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities.
J Nucl Med
; 64(5): 711-716, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36581374
11.
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma.
Blood Adv
; 7(2): 214-223, 2023 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36306337
12.
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Cancer Cell
; 41(1): 210-225.e5, 2023 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36584673
13.
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry.
J Cancer Res Clin Oncol
; 149(8): 4611-4621, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36167894
14.
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial.
Leukemia
; 36(12): 2845-2852, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36241697
15.
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial.
J Cancer Res Clin Oncol
; 148(10): 2611-2621, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34708297
Resultados
1 -
15
de 15
1
Próxima >
>>